🎥 Jakub Svoboda (Penn Medicine - Abramson Cancer Center) comments on the evolving landscape of cardiovascular surveillance in pts undergoing treatment for #Lymphoma, highlighting the need for individualized approaches due to limited data. Watch here: 👉 ow.ly/QK8n50SOfFj 👈 #LYMsm #HemOnc #ASCO24

Our own Dr. Tom Karasic spoke with OncLive.com about how the first-in-class p53 Y220C reactivator rezatapopt could turn the p53 Y220C mutation, which had previously been termed undruggable, into a tumor-agnostic target for patients w/ advanced #SolidTumors. spr.ly/6013Yf8ZD

Congratulations to Kevin B. Mahoney, Penn Medicine CEO, and Alina Mateo, MD, director of the Integrated Breast Center at Pennsylvania Hospital, who were recently named to City & State PA's inaugural Trailblazers in Health Care list. spr.ly/6010lBSTI

Our patients, including Becky Yu, and clinicians, including her oncologist, Penn Medicine - Abramson Cancer Center's Selina Luger, MD, were major contributors to a new cancer treatment advance for acute lymphocytic leukemia: the immunotherapy drug blinatumomab. ECOG-ACRIN Cancer Research Group spr.ly/6013lgONT

On a recent The Breast Cancer Research Foundation Investigating Breast Cancer Podcast episode, Penn Medicine - Abramson Cancer Center & PennSurgery's Lola Fayanju (she/her) explained how addressing racial disparities in #BreastCancer treatment can improve survival for people of color after a breast cancer diagnosis. spr.ly/6015lgTOX

Our own #CARTCellTherapy pioneer Dr. Carl June spoke to Forbes about the potential of using CAR T therapy to treat #glioblastoma. “I think about five years down the line, we’re going to have FDA-approved CARs for glioblastoma." spr.ly/6016l9UYO

In an interview at #ASCO24, Penn Medicine - Abramson Cancer Center's Dr. Ravi B. Parikh highlighted the promising future for integrating AI into cancer diagnosis, treatment planning, and drug discovery. VJ Oncology spr.ly/6011lir8z

Beth Sandy, MSN, CRNP, Penn Medicine - Abramson Cancer Center nurse practitioner, told Oncology Nursing News how oncology nurses & advanced practice providers should educate themselves on the latest genetic mutations and adverse events for non-small cell #LungCancer targeted therapies. spr.ly/6018laETy

Dr. Yu-Xiao Yang & team developed & internally validated a classification & regression tree to identify patient characteristics associated with risks of early mortality from treatment initiation for patients with #HepatocellularCarcinoma. JCO Clinical Cancer Informatics spr.ly/6019lxhZL

A lack of info, insufficient communication with providers, & emotional health barriers prevent women from prioritizing their health. "Finding cancers at an earlier stage is important for women to have better outcomes," per Dr. Emily Conant. Physician's Weekly spr.ly/6010lx7mi

Kara N. Maxwell, MD, PhD, discusses the need to improve genetic testing rates for BRCA mutations in the male population. Kara Maxwell Penn Medicine #OncClub #oncology onclive.com/view/review-hi…

As leukemia survivor Alexis Rodriguez fights another life-threatening health complication, her nursing team at Penn Medicine helped make another dream come true, putting together a magical wedding for her and her fiancé Jeff. spr.ly/6013m6nlF CBS Philadelphia

Penn Medicine and Parker Institute for Cancer Immunotherapy have renewed their collaboration to advance cancer #immunotherapy research at Penn Medicine - Abramson Cancer Center. The alliance will help to “quickly translate research findings into tomorrow’s cancer cures,” says Dr. Carl June. E. John Wherry spr.ly/6019mBxkW

.Penn Medicine - Abramson Cancer Center's Charu Aggarwal, MD, MPH, FASCO discusses results from a phase 2 trial evaluating the combo of CAN-2409 & valacyclovir and continued standard-of-care immune checkpoint inhibitors for patients with stage III/IV non–small cell lung cancer. OncLive.com #ASCO24 spr.ly/6010mBSYI

Two separate clinical trials have found that a class of drugs that stymie inflammation, JAK inhibitors, may improve the effectiveness of commonly used immunotherapies. Our own Dr. Andy Minn helped to lead the #LungCancer study. National Cancer Institute spr.ly/6017mjo1N

Our own Gary Freedman, MD, discussed the results of the recently published 30-year follow-up of the Scottish Breast Conservation Trial that examined the role of postoperative #radiotherapy after breast-conserving surgery for early #BreastCancer. Medscape spr.ly/6010mBLHY

Cancer survivor Jessy Kyle, who sang at the 2023 Philly Fights Cancer fundraising event for Penn Medicine - Abramson Cancer Center, has created a new bra line inspired by her medical journey, which included Hodgkin's lymphoma, a heart attack, & a kidney transplant. CBS Philadelphia spr.ly/6015mR1mc

Congrats to Ronald DeMatteo, MD, chair of PennSurgery, who has been appointed as the 2025 president of Society of Surgical Oncology. Dr. DeMatteo is nationally recognized for his expertise in treating and researching diseases of the liver, bile duct, gallbladder, and pancreas, among others.

“Good Day Philadelphia” weather anchor Sue Serio recently revealed that her annual #mammogram found #BreastCancer and that she’ll be off the air for several weeks. Also, our own Dr. Julia Tchou explains the benefits of early detection. PennSurgery spr.ly/6014mWG1o

On the Raising Health podcast, Dr. Bruce Levine (Bruce Levine, Ph.D. 🇺🇦) discussed the history of #CARTCellTherapy & what’s next in the field, including challenges scientists & industry must overcome to make CAR T more accessible. spr.ly/6013mRrEd